FDA approves apalutamide for castration-resistant prostate cancer.
Jeff Cineas, PharmD Candidate
Advertisement
Articles by Jeff Cineas, PharmD Candidate
Advertisement
Latest Updated Articles
Apalutimide for Prostate Cancer: What to KnowApril 4th 2018
Advertisement
Advertisement
Trending on Drug Topics
1
Measles Cases Surpass 2000 in 2026, Threatening US Elimination Status
2
Naloxone Access Continuously Improves as Gaps Persist in Pharmacy
3
Study Finds No Link Between Prenatal Acetaminophen Use and Autism, ADHD
4
Rezdiffra Reduces Cardiovascular, Liver-Related Risk Markers in MASH
5